Management implications associated with switching from vitamin K antagonist anticoagulants to direct oral anticoagulants.

Authors :: Pia-Morandeira A
Cinza-Sanjurjo S
Portela-Romero M
Source :: Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2022 Apr; Vol. 75 (4), pp. 345-347. Date of Electronic Publication: 2021 Nov 30.
Publication Year :: 2022

Subjects :: Administration, Oral
Anticoagulants therapeutic use
Fibrinolytic Agents therapeutic use
Humans
Vitamin K
Warfarin therapeutic use
Atrial Fibrillation complications
Atrial Fibrillation drug therapy
Stroke complications

Full Text Access

Tools